Back to results
US 2025/0049704 A1Published application
Hydrocortisone oral liquid formulations
AssigneeEton Pharmaceuticals, Inc.
InventorsDanka RADOSAVLJEVIC, Sean BRYNJELSEN, Romona BHATTACHARYA, Kalyan KATHALA
Life of this patent
Estimating the term…
Abstract
Provided herein are oral liquid formulations of hydrocortisone. Also provided herein are methods of making and using hydrocortisone oral liquid compositions for the treatment of certain diseases including endocrine disorders, rheumatic disorders, collagen diseases, dermatologic diseases, and others.
Claims25
A liquid pharmaceutical composition comprising:
- hydrocortisone or a pharmaceutically acceptable salt thereof;
- and
- a nonaqueous liquid carrier, wherein the nonaqueous liquid carrier is present in the liquid pharmaceutical composition in an amount of from about 70% weight by weight (% wt) to about 99.9% wt;
- and
- wherein the liquid pharmaceutical composition is an oral liquid, and wherein the liquid pharmaceutical composition contains less than 5% wt of water.
2 more elements
Dependencies are inferred from the claim text.